Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. - Wikidata - wikimedia - TriplyDB

Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q50724186

about

Self management for patients with chronic obstructive pulmonary disease Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review COPD and exercise: does it make a difference?Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA COPD: the patient perspective COPD and its comorbidities: Impact, measurement and mechanisms Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management Underrecognized comorbidities of chronic obstructive pulmonary disease Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease Ageing and the epidemiology of multimorbidity Predictive medicine: outcomes, challenges and opportunities in the Synergy-COPD project Vitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of Ageing Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?Influence of a 10-Day Mimic of Our Ancient Lifestyle on Anthropometrics and Parameters of Metabolism and Inflammation: The "Study of Origin"Walking towards personalized medicine in pulmonary rehabilitation: Comorbidities and COPD.Cardiovascular risk, chronic obstructive pulmonary disease and pulmonary rehabilitation: Can we learn from cardiac rehabilitation?Living With Chronic Lower Pulmonary Disease: Disruptions of the Embodied Phenomenological Self.The COgnitive-Pulmonary Disease (COgnitive-PD) study: protocol of a longitudinal observational comparative study on neuropsychological functioning of patients with COPD Derivation and validation of clinical phenotypes for COPD: a systematic review.Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.Determination of Pain Phenotypes in Knee Osteoarthritis: A Latent Class Analysis Using Data From the Osteoarthritis Initiative.Do self-management interventions in COPD patients work and which patients benefit most? An individual patient data meta-analysis.From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration.Cytokine inhibition in the treatment of COPD.A study of chronic obstructive pulmonary disease-specific causes of osteoporosis with emphasis on the emphysema phenotype Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis A randomized clinical trial to assess the influence of a three months training program (gym-based individualized vs. calisthenics-based non-invidualized) in COPD-patients.Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease.Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patients Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations.Epidemiology and clinical impact of major comorbidities in patients with COPD.The mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease.Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.A simplified score to quantify comorbidity in COPD

P2860

Q24197903-984121ED-FE40-4681-A502-F67AB4F05B98 Q24288655-1EF8FBBE-F435-416D-87AB-C9A491CCF331 Q26740768-87D8ABD0-253D-43F6-A083-B19A909D2164 Q26749418-76EF5215-B73E-4DDC-9388-9B866618FB2F Q26752988-2BAED739-3577-41B7-8000-D843A1392807 Q26764894-39172147-996E-4156-BCC8-CFD2C1E545FB Q26786812-A605778A-4D4A-4A6F-BCD6-4A5821634ABD Q26799659-54BE8B1C-3C3F-49BC-B078-3892651FB52D Q26800282-A19ED75E-D4C7-4A43-A1AA-B8B774E32805 Q27000043-269BE831-E030-44A3-A918-6E7BBD81B7E9 Q27012096-9EDEA4F4-34B5-4908-AD6D-86889B5B9B88 Q27014689-C7BB3361-A70F-43DA-8D72-83D323D7C589 Q28397350-04D2C982-882B-4F84-A235-E3EA94B4913E Q28596796-CB6D384E-E3C9-4FED-92F3-F011DBE05BBA Q28829810-75CAC6B7-7563-44BD-990E-C81F6836F920 Q30248639-1D71A3FA-C971-4C77-8C39-3E99567360C6 Q30251588-DE8D1F29-89AF-43CC-B762-89C59CB598D3 Q30401577-753F58FA-5F40-4C4D-846F-38453171AC5C Q30573818-2692F8B0-F279-4054-BE3F-E64BA25028C3 Q30653887-35080485-42E2-4522-BF72-30B5A59E64F5 Q30989356-98EBD70C-D065-414F-B662-D1A10C411AEF Q30998667-0A5874E8-12B5-47C0-942A-2BAC38973C45 Q31130054-2B8F56A1-31F6-4BE9-9814-8C60AF05D406 Q31160925-5D7E8D55-7862-4441-8A8C-6A953ED8F181 Q33568552-9DC00DC3-2B6E-4FBE-94F9-177A04D65054 Q33588471-D8F814AB-972C-42BD-8B73-A69805C181C7 Q33604883-45CCF006-B4F8-4622-AA08-6E9B460F1C34 Q33612156-A7ADE2BA-2BB8-464B-8F2D-BBCCA1D6FC84 Q33641597-4647FAA1-3445-43AD-AC73-CF90CDCDB4BE Q33649907-47CA4D92-9A0C-4E78-B3D1-00E806A73E37 Q33704896-2311FA50-143A-45D1-8A63-ECEED660496B Q33707570-2C6A23A5-A386-4F6E-B9D1-AAFF245DB0DE Q33732176-54E4743F-146E-4085-B10C-D3C8B86C81CA Q33820309-CC9E7306-EF6D-4EDF-ACDC-48819B36F12E Q34134841-BD737C83-2339-4EB4-8F47-094C1012444D Q34352974-BDD466B7-FB29-4496-A314-44ADF50D21CB Q34511113-995C3606-09C8-42E2-8106-05CB5EF1E1B7 Q34550471-F4DD61DB-6BA0-44EE-AEAB-58BA718BC9F2 Q34636461-FDC3BBF9-66D4-4F58-B935-3B5760E8C3A2 Q34712570-345A0358-91D9-4179-B80F-07F03A8BF8EA

P2860

Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q50724186

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Clusters of comorbidities base ...... obstructive pulmonary disease.

@en

Clusters of comorbidities base ...... obstructive pulmonary disease.

@nl

type

label

Clusters of comorbidities base ...... obstructive pulmonary disease.

@en

Clusters of comorbidities base ...... obstructive pulmonary disease.

@nl

prefLabel

Clusters of comorbidities base ...... obstructive pulmonary disease.

@en

Clusters of comorbidities base ...... obstructive pulmonary disease.

@nl

P1433

Q50724186-120F0835-5A37-4777-8939-31D8132CC65F

P1476

Q50724186-7757F2A8-FDBF-4013-9F99-FD87DD221CDA

P2093

Q50724186-1815D50B-FBF5-4FFB-B4F7-8836BC9B0DE7

Q50724186-2F34CC40-5135-41F4-8424-B697F3EBACAC

Q50724186-5BE5C141-A1F0-4C33-AD63-BDC5B8729C7A

Q50724186-5CAA9468-8F48-44C5-8803-07A6BA2570FA

Q50724186-7B41F142-C5B9-44B9-BEAF-D65C368F8DCB

Q50724186-900EA77C-6925-4374-93B9-800C50F4CA28

Q50724186-91F1B8B1-DB9D-4FD9-96A3-E4ACB644545B

P2860

Q50724186-00F59BA1-F612-4DC1-B32A-2960F9349C5E

Q50724186-01A2EE76-E975-467C-ACC8-480E9E19DA91

Q50724186-032BB3B7-0BB2-4FB0-9722-4D96F9BEAA6A

Q50724186-033F6F2F-DE6B-48D2-B3A9-F852DFFF09C1

Q50724186-05567E87-523A-4315-8E3A-BE73C99E45F6

Q50724186-07EBF233-8F87-4AC0-86B1-C6276C4E4683

Q50724186-0926172E-C6EB-4404-BFCC-25FA372ABC99

Q50724186-0D79C7CD-2A20-4E6A-9666-B2F338363F0F

Q50724186-15CF1228-D6AB-4EBB-ADC3-8BEA97A8CC65

Q50724186-1DD5F74F-FD5B-4728-9DD1-483434183231

P304

Q50724186-81A116D7-99F8-4340-ADF8-73D350E45E7B

P31

Q50724186-1A281D7C-C391-45FA-9C06-59674462DBA8

P356

Q50724186-62F03BBA-1867-4E37-B650-1110F828BDB5

P407

Q50724186-D477B9D9-092C-43CA-92B3-CF1EDC7057D4

P433

Q50724186-4243FD26-E877-449B-A1DC-D46B999F73C3

P478

Q50724186-35878B0A-EA5D-4EB8-9CE8-3F8D1DE39DE1

P50

Q50724186-C075DEF3-738A-409C-9A77-1784378B47A2

Q50724186-ED2F1488-D752-4ED0-BBD0-01E4959474A0

Q50724186-F67E1867-F136-453B-A69A-EFDAC33C76BE

P577

Q50724186-895AD681-5566-4487-B22B-658AAF552DAC

P698

Q50724186-19327D31-D2B4-476B-A48F-AFC4CD622D62

P921

Q50724186-8162C48A-25F9-4751-AC53-6BC7A45B7BF2

Q50724186-DA383EF5-BABC-408D-BED3-0A01CFA67D34

P356

RCCM.201209-1665OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Clusters of comorbidities base ...... obstructive pulmonary disease.

@en

P2093

Erica P A Rutten

http://www.w3.org/2001/XMLSchema#string

Jos Op 't Roodt

http://www.w3.org/2001/XMLSchema#string

Lowie E G W Vanfleteren

http://www.w3.org/2001/XMLSchema#string

Miriam Groenen

http://www.w3.org/2001/XMLSchema#string

Piet L B Bruijnzeel

http://www.w3.org/2001/XMLSchema#string

Swetlana Gaffron

http://www.w3.org/2001/XMLSchema#string

Vanessa P M van Empel

http://www.w3.org/2001/XMLSchema#string

P2860

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.

Characteristics of Dutch and Swiss primary care COPD patients - baseline data of the ICE COLD ERIC study.

Patterns of multimorbidity in the aged population. Results from the KORA-Age study

Characterisation of COPD heterogeneity in the ECLIPSE cohort

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype

The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.

Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality

Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort.

P304

728-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201209-1665OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

187

http://www.w3.org/2001/XMLSchema#string

P50

Martijn A Spruit

Frits M E Franssen

Emiel F M Wouters

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23392440

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease